Mechanisms of Glybenclamide-Mediated Anti-Arrhythmia and Ischemic Conditionining in a Rat Model of Myocardial Infarction: Role of yohimbine Treatment

Turkish Journal of Medical Sciences

Volumn 34, Issue 1, 2004, Pages 21-27

  Bozdoǧan, Ömer ^a   Gonca, Ersöz ^a   Suveren, Eylem ^a   Gökçe, Fatih ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Arrhythmia; ATP sensitive potassium channels; Hypoglycemic sulfonylurea compounds; Myocardial ischemia; Yohimbine

Indexed keywords

ADENOSINETRIPHOSPHATE; DRUG DOSAGE; HISTOLOGY; POTASSIUM;

ENFARCT SIZE; HYPOGLYCEMIC AGENTS;

BIOMEDICAL ENGINEERING;

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; POTASSIUM CHANNEL; YOHIMBINE;

ADRENERGIC ACTIVITY; ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; RAT; SURVIVAL RATE;

EID: 1542316043     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wilde AAM, Janse MJ. Electrophysiological effects of ATP sensitive potassium channel modulation: Implications for arrhythmogenesis. Cardiovasc Res 28: 16-24, 1994.
2. Kontor PF, Coetzee WA, Carmeliet EE et al. Reduction of ischemic K loss and arrhythmias in rat hearts: Effect of glibenclamide, a Sulphonylurea. Circ Res 66: 478-485, 1990.
3. Roegel JC, De Jong W, Monassier L et al. Comparative effects of idozoxan, prazosin and yohimbine on coronary ligation-induced arrhythmias in spontaneously hypertensive rats. J Cardiovasc Pharmacol 27: 226-234, 1996.
4. Tosaki A, Szerdahely P, Engelman RM et al. Potassium channel openers and blockers: Do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat heart. J Pharmacol and Exp Ther 267: 1355-1362, 1993.
5. Bozdoǧan Ö, Lepran I, Papp JG. Effect of glimepride and glibenklamide, inhibitors of ATP dependent K+ channel, on ischemia-reperfusion induced arrhythmias in rats. Acta Physiol Hung 84: 265-266, 1996.
6. El-Reyani N, Bozdoǧan Ö, Baczko I et al. Comparison of the efficacy of glibenclamide and glimepride in reperfusion-induced arrhythmias in rats. European J Pharmacol 365: 187-192, 1999.
7. Cole WC, McPherson CD, Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res 69: 571-581, 1991.
8. Bernauer W. Concerning the effect of the K+ channel blocking agent glibenclamide on ischemic and reperfusion arrhythmias. Eur J Pharmacol 326: 147-156, 1997
9. Valle HF, Lascano EC, Negroni JA et al. Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep. Cardiovasc Res 50: 474-485, 2001.
10. Bozdoǧan Ö, Lepran I, Papp JG. Effect of the combination of glibenclamide, an ATP dependent potassium channel blocker and metoprolol, a cardioselective b-adrenoceptor blocker, during myocardial infarction in conscious rats. Turk J Med Sci 30: 517-523, 2000.
11. Bernauer W. Antiarrhythmic and antinecrotic effects of yohimbine stereoisomers in rats during coronary occlusion and reperfusion. Basic Res Cardiol 85: 132-141, 1990.
12. Yamaguchi N, Lamontagne D, Boudreau G et al. Effects of yohimbine and desipramine on cardiac noradrenaline release and ventricular arrhythmias during acute coronary artery occlusion and reperfusion in anesthetized dogs. Can J Pharmacol 65: 2244-2253, 1987.
13. Dikshit M, Kar K, Srimal RC. Effect of alpha-adrenergic receptor blockers on the vulnerability of cat heart to ventricular fibrillation. Arch Int Pharmacodyn Ther 302: 119-127, 1989.
14. Bernauer W, Ernenputsch I. Antagonistic effects of alpha-adrenoceptor blocking agents on arrhythmias, enzyme release, and myocardial necrosis in isolated rat hearts with coronary occlusion and reperfusion. Naunyn Schmiedebergs Arch Pharmacol 338: 88-95, 1988.
15. Lepran I, Koltai M, Siegmund W et al. Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats. J Pharmacol Methods 9: 219-230, 1983.
16. Walker MJA, Curtis MJ, Hearse DJ et al. The lambeth conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res 22: 447-455, 1988.
17. Forfar JC, Riemersma RA, Oliver MF. Alpha-adrenoceptor control of norepinephrine release from acutely ischemic myocardium: effects of blood flow, arrhythmias, and regional conduction delay. J Cardiovasc Pharmacol 5: 752-759, 1983.
18. Bozdoǧan Ö, Ekerbiçer N, Suveren E et al. Effects of adrenaline pretreatment on the arrhythmias observed following ischemia and reperfusion in conscious and anesthetized rats. Exp Clin Cardiol 7: 20-24, 2002.
19. Oe K, Sperlagh B, Santha E et al. Modulation of norepinephrine release by ATP-dependent K(+) channel activators and inhibitors in guinea-pig and human isolated right atrium. Cardiovasc Res 43: 125-134, 1999.
20. Vegh AA, Parrat JR. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anesthetized dogs. Cardiovasc Res 55: 53-63, 2002.